Nonetheless, for both genes a significant frequency of tumour-specific methylation was observed in primary tumours, which was associated with transcriptional silencing in medulloblastoma cell lines, indicating epigenetic inactivation and candidate tumour suppressor roles for S100A6 and S100A10 in primary medulloblastoma development. The gene discussed is S100A6; the disease is medulloblastoma.